{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:16:47Z","timestamp":1791191807764,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.jsat.2009.07.002","type":"journal-article","created":{"date-parts":[[2009,10,3]],"date-time":"2009-10-03T19:56:06Z","timestamp":1254599766000},"page":"83-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Preference for buprenorphine\/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: A prospective, multicenter study"],"prefix":"10.1016","volume":"38","author":[{"given":"Jean-Pierre","family":"Daulou\u00e8de","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Caer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Galland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Villeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Brunelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Bachellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Piquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Harbonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Leglise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Courty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2009.07.002_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugalcdep.2006.09.012","article-title":"Abuse liability of buprenorphine\u2013naloxone tablets in untreated IV drug users","volume":"88","author":"Alho","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2009.07.002_bib2","series-title":"Maintenance treatment of heroin addiction: Evidence at the crossroads","first-page":"190","article-title":"Buprenorphine prescribed by general practitioners\u2014a safe means of increasing patient access to treatment?","author":"Auriacombe","year":"2003"},{"key":"10.1016\/j.jsat.2009.07.002_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1081-1206(10)61957-6","article-title":"Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis","volume":"89","author":"Bachert","year":"2002","journal-title":"Annals of Allergy, Asthma & Immunology"},{"key":"10.1016\/j.jsat.2009.07.002_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11606-006-0050-y","article-title":"Patient satisfaction with primary care office-based buprenorphine\/naloxone treatment","volume":"22","author":"Barry","year":"2007","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2009.07.002_bib5","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1360-0443.2007.01979.x","article-title":"A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence","volume":"102","author":"Bell","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2009.07.002_bib6","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1086\/508184","article-title":"Buprenorphine use: The international experience","volume":"43","author":"Carrieri","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2009.07.002_bib7","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1360-0443.2005.01271.x","article-title":"Harm reduction interventions, behaviours and associated health outcomes in France, 1996\u20132003","volume":"100","author":"Emmanuelli","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2009.07.002_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11920-007-0046-2","article-title":"Why buprenorphine is so successful in treating opiate addiction in France","volume":"9","author":"Fatseas","year":"2007","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.jsat.2009.07.002_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/10550490701860971","article-title":"Long-term treatment with buprenorphine\/naloxone in primary care: Results at 2\u20135 years","volume":"17","author":"Fiellin","year":"2008","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2009.07.002_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMoa055255","article-title":"Counseling plus buprenorphine\u2013naloxone maintenance therapy for opioid dependence","volume":"355","author":"Fiellin","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2009.07.002_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/ADM.0b013e31809b5df2","article-title":"Two-year experience with buprenorphine\u2013naloxone (Suboxone) for maintenance treatment of opioid dependence within a private practice setting","volume":"1","author":"Finch","year":"2007","journal-title":"Journal of Addictive Medicine"},{"key":"10.1016\/j.jsat.2009.07.002_bib12","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1046\/j.1360-0443.2002.00189.x","article-title":"Trends in opiate and opioid poisonings in addicts in north-east Paris and suburbs, 1995\u201399","volume":"97","author":"Gueye","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2009.07.002_bib13","author":"International Harm Reduction Association"},{"key":"10.1016\/j.jsat.2009.07.002_bib14","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0376-8716(03)00057-7","article-title":"Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: Why the 4:1 ratio for treatment?","volume":"70","author":"Mendelson","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2009.07.002_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1360-0443.2001.96226710.x","article-title":"Injecting misuse of buprenorphine among French drug users","volume":"96","author":"Obadia","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2009.07.002_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/1747-597X-3-16","article-title":"A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine\/naloxone combination (Suboxone)","volume":"3","author":"Simojoki","year":"2008","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.jsat.2009.07.002_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130000637","article-title":"Effects of buprenorphine\/naloxone in opioid-dependent humans","volume":"154","author":"Stoller","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jsat.2009.07.002_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0376-8716(02)00312-5","article-title":"Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France","volume":"69","author":"Vidal-Trecan","year":"2003","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547209001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547209001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:35:00Z","timestamp":1760038500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547209001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0740547209001202"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2009.07.002","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preference for buprenorphine\/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: A prospective, multicenter study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2009.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}